The Current Market Cap of CIPLA is ₹78,007.9 Cr. Current Share Price: ₹967.0, Updated EOD on : Sep 24,2021.
| Market Cap Change(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.5% |
5.5% |
19.6% |
| SENSEX | 2.7% |
7.3% |
54.2% |
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹78,007.9 Cr | 1.5% | 5.5% | 19.6% | FULL ANALYTICS | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹184,677.0 Cr | -0.1% | -0.3% | 47.1% | FULL ANALYTICS | |
| DIVIS LABORATORIES | ₹135,437.0 Cr | 1.7% | 7.3% | 53.8% | FULL ANALYTICS | |
| DR REDDYS LABORATORIES | ₹79,751.6 Cr | -1.9% | 4.5% | -9% | FULL ANALYTICS | |
| PIRAMAL ENTERPRISES | ₹66,165.9 Cr | 5.6% | 6.6% | 95.6% | FULL ANALYTICS | |
| GLAND PHARMA | ₹63,188.6 Cr | -1.6% | 2.6% | NA | FULL ANALYTICS | |
| CADILA HEALTHCARE | ₹57,815.9 Cr | 1.6% | 3.3% | 37.2% | FULL ANALYTICS | |
| TORRENT PHARMACEUTICALS | ₹52,458.9 Cr | 0.2% | 1.5% | 7.4% | FULL ANALYTICS | |
| ALKEM LABORATORIES | ₹47,848.1 Cr | 5.7% | 4.8% | 38.4% | FULL ANALYTICS | |
| ABBOTT INDIA | ₹45,025.5 Cr | 3.1% | 12% | 35.9% | FULL ANALYTICS | |
| BIOCON | ₹43,245.6 Cr | -2.6% | 5.2% | -19% | FULL ANALYTICS | |
| AUROBINDO PHARMA | ₹42,310.6 Cr | 1.4% | 3.7% | -7.3% | FULL ANALYTICS | |
| LUPIN | ₹42,052.3 Cr | -1.1% | 0.1% | -13.4% | FULL ANALYTICS | |
| LAURUS LABS | ₹32,722.0 Cr | -4.5% | -7.3% | 108% | FULL ANALYTICS | |
| IPCA LABORATORIES | ₹30,471.2 Cr | -0.8% | -1.1% | 11.8% | FULL ANALYTICS | |
| PFIZER | ₹26,098.6 Cr | -0.9% | -0.1% | 16.1% | FULL ANALYTICS | |
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹25,385.5 Cr | -2% | -1.2% | -11.6% | FULL ANALYTICS | |
| AJANTA PHARMA | ₹18,803.3 Cr | -2.1% | -3.4% | 37.5% | FULL ANALYTICS | |
| SANOFI INDIA | ₹18,606.6 Cr | 3.6% | -8.2% | -5.3% | FULL ANALYTICS | |
| NATCO PHARMA | ₹16,036.6 Cr | -6.3% | -1.5% | 0.6% | FULL ANALYTICS | |
| ALEMBIC PHARMACEUTICALS | ₹15,562.9 Cr | 1.1% | 5.9% | -10.8% | FULL ANALYTICS | |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE DIVIDEND STABILITY | 3% | 7.3% | 49.6% |
| S&P BSE MOMENTUM | 2.8% | 7.2% | 41.8% |
| S&P BSE SENSEX50 | 2.6% | 7.2% | 54.8% |
| S&P BSE LARGECAP | 2.5% | 7.3% | 54.6% |
| S&P BSE LARGE MIDCAP | 2.5% | 7.6% | 56.6% |
| S&P BSE 100 | 2.5% | 7.4% | 55.5% |
| S&P BSE CARBONEX | 2.5% | 7.2% | 54.9% |
| S&P BSE 250 LARGEMIDCAP | 2.5% | 7.6% | 57.8% |
| S&P BSE 200 | 2.5% | 7.6% | 57.5% |
| S&P BSE 100 LARGECAP TMC | 2.5% | 7.4% | 55.3% |
| S&P BSE 500 | 2.5% | 7.7% | 59.1% |
| S&P BSE ALLCAP | 2.4% | 7.7% | 60.1% |
| S&P BSE GREENEX | 2.4% | 6.9% | 56% |
| S&P BSE 100 ESG INDEX | 2.1% | 6.5% | 54.7% |
| MFG | 1.6% | 5.8% | 41.7% |
| S&P BSE HEALTHCARE | 0.4% | 1.9% | 30.3% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 50 | 2.6% | 7.3% | 54.9% |
| NIFTY 200 | 2.5% | 7.8% | 57.6% |
| NIFTY LARGE MIDCAP 250 | 2.5% | 8.3% | 63.2% |
| NIFTY 100 | 2.5% | 7.5% | 55.4% |
| NIFTY 500 | 2.5% | 7.8% | 59.1% |
| NIFTY50 EQUAL WEIGHT | 2.4% | 7.5% | 65.3% |
| NIFTY500 MULTICAP 50:25:25 | 2.4% | 8.1% | NA |
| NIFTY 100 EQUAL WEIGHT | 2.2% | 7.9% | 63.1% |
| NIFTY ALPHA LOW-VOLATILTY 30 | 2.1% | 8.2% | 47.8% |
| NIFTY 100 ALPHA 30 | 1.8% | 6.6% | NA |
| NIFTY100 LOW VOLATILITY 30 | 1.6% | 7.1% | 46.8% |
| NIFTY PHARMA | 1.4% | 3.3% | 16.7% |
| NIFTY HEALTHCARE | 0.6% | 1.5% | NA |
#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014
Contact Us
support@smart-investing.in
Smart-Investing.in
Pricing
Video Course
Blog
Tools
Screener
Compare
Analyze Portfolio
© 2019 - 2021 Smart-Investing.in. All rights reserved. Built with ❤️ in India
Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed.
We don't make any Buy/Sell recommendations and don't give any price targets.
This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only.
Please do your own research before making any investment decisions.
Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose. Past Performance is not indicative of future returns.
We have affiliate relationships with Amazon and Zerodha.
Financial Data Source: Accord Fintech |
Methodology |
Privacy Policy |
Terms & Conditions |
SEBI Registered Research Analyst Registration No : INH000007377 |
Disclosure